Search research articles
Contact Us
Filters
Showing results (71-80 of 76) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 76 results.
Circulation
|
April 18, 2012
Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport
Robert S Rosenson, H Bryan Brewer, W Sean Davidson, et al.
The New England Journal of Medicine
|
March 24, 2006
Effect of ACAT inhibition on the progression of coronary atherosclerosis
Steven E Nissen, E Murat Tuzcu, H Bryan Brewer, et al.
The Journal of Biological Chemistry
|
August 25, 2006
ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis
Charles W Joyce, Elke M Wagner, Federica Basso, et al.
American Heart Journal
|
December 19, 2015
Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial
Stephen J Nicholls, A Michael Lincoff, Philip J Barter, et al.
Lancet (London, England)
|
October 2, 2019
Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study
Ron Waksman, Carlo Di Mario, Rebecca Torguson, et al.
The New England Journal of Medicine
|
May 18, 2017
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
A Michael Lincoff, Stephen J Nicholls, Jeffrey S Riesmeyer, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 76) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 76 results.
Circulation
|
April 18, 2012
Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport
Robert S Rosenson, H Bryan Brewer, W Sean Davidson, et al.
The New England Journal of Medicine
|
March 24, 2006
Effect of ACAT inhibition on the progression of coronary atherosclerosis
Steven E Nissen, E Murat Tuzcu, H Bryan Brewer, et al.
The Journal of Biological Chemistry
|
August 25, 2006
ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis
Charles W Joyce, Elke M Wagner, Federica Basso, et al.
American Heart Journal
|
December 19, 2015
Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial
Stephen J Nicholls, A Michael Lincoff, Philip J Barter, et al.
Lancet (London, England)
|
October 2, 2019
Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study
Ron Waksman, Carlo Di Mario, Rebecca Torguson, et al.
The New England Journal of Medicine
|
May 18, 2017
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
A Michael Lincoff, Stephen J Nicholls, Jeffrey S Riesmeyer, et al.
Page
of 8